Parkinson's disease is another disorder notorious for claiming victims in the older demographic and presents in tremors and ...

We've got Chairman, President and CEO, Mike Mahoney; and Chief Medical Officer, Dr. Ken Stein here in Boston with the TD Cowen team. Thank you, guys. Yes. Sure. Good morning, everybody. Maybe a few ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

TidalHealth Peninsula Regional recently performed its 700th WATCHMAN procedure, marking a significant milestone for the medical center, according to a community announcement. The WATCHMAN procedure is ...

(Ad) Peter Smith lives an active life. At 67, he loves to garden, work outside with his hands and get out on his bicycle. So, when doctors told him he couldn’t cycle anymore due to the blood thinners ...

Boston Scientific tops Q4 estimates, but shares sink on supply woes and EP losses. Can strong growth drivers fuel a 2026 rebound?

Boston Scientific’s electrophysiology business stumbled as competition from Medtronic, Johnson & Johnson, Abbott, and others in the pulsed-field ablation (PFA) space intensified. Marie Thibault, a ...

Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp.’s shares plummeting nearly 20% this week. Even fewer have given up on their bullish calls since. It ...

A general view of a Boston Scientific advertisement during a women's college lacrosse game between the Notre Dame Fighting Irish and the Boston College Eagles on March 16, 2024 at Alumni Stadium in ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was ...

Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings ...

Boston Scientific’s fourth-quarter profit and sales climbed but the medical-device maker issued a soft forecast for the year, sending shares down in premarket trading. The company logged earnings of ...